EurekAlert! -
3 May 2015 06:00
(University of Cincinnati Academic Health Center) A University of Cincinnati-led research team has found that generic formulations of tacrolimus, a drug used post-transplant to lower the risk of organ rejection, are just as good as the name-brand version.
Share this Article